News and Treatment Updates
Here's where you'll find a regularly updated, broad range of articles written by the AAMDSIF team, allied health organizations and news organizations. By staying well-informed, patients and families are practicing a form of self-support that will help them be more effective self-advocates when engaging with health care providers.
Original Publication Date
Article Source
External Web Content
Highlights -Considerable heterogeneity exists in germline testing implementation across hematopoietic stem cell transplantation centers in the United States. -Lack of standardized protocols affects the timing of testing and inconsistent sample collection workflows. -Barriers to…
Reduced Cumulative Post-Transplant Cyclophosphamide Exposure Is Associated with Increased Acute and Chronic Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
Original Publication Date
Article Source
External Web Content
Highlights Reduced cumulative post-transplant cyclophosphamide (<100 mg/kg) was associated with increased acute GVHD. Lower PTCy exposure independently increased moderate-to-severe chronic GVHD and second-line GVHD treatment. Reduced PTCy exposure did not significantly affect…
Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases
Original Publication Date
Article Source
External Web Content
ABSTRACT Introduction Central venous catheter (CVC) insertion is frequently required in patients with haematological diseases. Despite limited evidence, thrombocytopenia often prompts prophylactic platelet transfusion before catheterisation. Methods We conducted an observational…
Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models
Original Publication Date
Article Source
External Web Content
Key Points Ziftomenib shows pronounced preclinical activity in the menin-KMT2A–dependent leukemia models, including patient-derived xenografts. Ziftomenib demonstrates potent activity against a subset of the drug-induced MEN1 mutations found in patients with acute myeloid…
Post-transplant hypomethylating agents plus venetoclax maintenance improves survival in high-risk myeloid malignancies: A matched cohort study
Original Publication Date
Article Source
External Web Content
Relapse is the leading cause of allogeneic hematopoietic stem cell transplant (allo-HSCT) failure in myeloid neoplasms [1]. Patients receiving reduced-intensity conditioning (RIC) regimens have a higher risk of post-transplant relapse compared to those undergoing myeloablative…
Stag2-dependent chromatin remodeling enforces the erythroid-specific Gata1 cistrome
Original Publication Date
Article Source
External Web Content
Key Points Stag2 reprograms Gata1 cistrome specificity via chromatin accessibility, a key determinant of transcription factor lineage discrimination. Loss of the Stag2 rheostat causes accessibility-driven Gata1 retargeting, providing a mechanistic framework for dyserythropoiesis…
Long-Term Gynecologic and Reproductive Health in Female Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis of Prevalence
Original Publication Date
Article Source
External Web Content
Allogeneic hematopoietic stem cell transplantation (allo-HCT) remains a potentially curative therapy for various hematologic malignancies, bone marrow failure syndromes, and selected nonmalignant disorders. Advances in conditioning regimens, graft-versus-host disease (GVHD)…
Real-world pharmacokinetics of venetoclax in patients with acute myeloid leukemia in Japan
Original Publication Date
Article Source
External Web Content
Abstract Venetoclax (VEN) combined with azacitidine (AZA) or low-dose cytarabine (LDAC) has significantly improved outcomes for older patients with acute myeloid leukemia (AML). However, severe cytopenia often leads to treatment interruptions. Previous literature has reported…
Patient and oncologist expectations of functional prognosis among older adults with acute myeloid leukemia
Original Publication Date
Article Source
External Web Content
Key Points Older adults with AML have different expectations compared to their oncologist regarding how their physical function will change. Future research is needed to understand the clinical impact of discordant expectations and how to support communication about functioning…
Clinical heterogeneity and outcome of acquired PRCA: a multicenter European study
Original Publication Date
Article Source
External Web Content
Key Points PRCA shows marked diagnostic heterogeneity, where molecular data can help identify challenging secondary forms, such as MDS-associated cases. Early initiation of CyA improves outcomes; mTORi are valuable second-line treatment. Infection related mortality remains non…
